Company attributes
Other attributes
Aju IB Investment is a venture capital firm in South Korea that focuses on providing investments for SMEs across all stages of development. Founded 1974 in Yeoksamdong, South Korea, it invests in late stage ventures. Its portfolio companies include Seer, SparkPlus, FamePick, Arcellx, Amphivena Therapeutics, Trefoil Therapeutics, Tibit Communications, Kymera Therapeutics, and Albam. As of March 2020, Aju IB Investment has made 27 investments. Their most recent investment was on December 17, 2019, when Seer raised $55M. Aju IB Investment has had nine exits, the most notable of which include Synlogic, Apellis Pharmaceuticals, and Molecular Templates. The company has raised a single venture fund, AJU IB Investment.